Dec 2 CRM call a bit sus, don’t you think?

[anonymous]

Leadership training and resource update, ya right.

 

[anonymous]

Worry not little one

 

[anonymous]

Every business unit is having a call before the end of the year. Respi is Dec 5. Just closing out the year I’m guessing.

 

[anonymous]

Every business unit is having a call before the end of the year. Respi is Dec 5. Just closing out the year I’m guessing.

 

[anonymous]

No kidding look at what happened to eye care and respiratory today!

 

[anonymous]

No kidding look at what happened to eye care and respiratory today!

Hahaha!

Close out they were. ("Closing Time" song playing in background.)

 

[anonymous]

Hahaha!

Close out they were. ("Closing Time" song playing in background.)

Too soon…think we have one more year for that call. Merry Christmas!

 

[anonymous]

We’ll see what tomorrow says of the union for eye care is all about

 

[anonymous]

Even if there is truth to any of this it won’t happen over night. Novartis must be putting this out there now to see what kind of interest there is. Both EC and respi will be safe for at least another 8-12 months if not longer. You don’t just sell a product or division in 2 months time.

 

[anonymous]

Someone on another thread made a good point. These plans are all made well in advance and by the time they hit the media they are definitely already in action. I have believed in Novartis for so long and I’m done. Wake up call for sure

 

[anonymous]

Does anyone care any more? I tried to stay positive and be patient. This franchise is a cesspool. These leaders are jokes. There are some good people here but most of the leaders ABL and up are only trying to cover their asses.

we’re getting a decent paycheck this trimester & our entresto performance went down. Riddle me that. Somehow our comp group placement beat the system. It’s messed u though.

 

[anonymous]

Does anyone care any more? I tried to stay positive and be patient. This franchise is a cesspool. These leaders are jokes. There are some good people here but most of the leaders ABL and up are only trying to cover their asses.

we’re getting a decent paycheck this trimester & our entresto performance went down. Riddle me that. Somehow our comp group placement beat the system. It’s messed u though.

My territory is doing fairly well with Entresto and getting paid almost nothing since the switch to TRX. Have done very well with Leqvio, but team goals combined with no sales data and other sales units getting credit for my partner and my work, I’m feeling like Clark Griswold opening the “Jelly of the Month” subscription for Christmas. Never been so demotivated.

 

[anonymous]

My territory is doing fairly well with Entresto and getting paid almost nothing since the switch to TRX. Have done very well with Leqvio, but team goals combined with no sales data and other sales units getting credit for my partner and my work, I’m feeling like Clark Griswold opening the “Jelly of the Month” subscription for Christmas. Never been so demotivated.

Its the gift that keeps on giving

 

[anonymous]

Oh for sure… just like the “Orion Training Call” an hour and a half training call that was an hour and fifteen minutes of performance and strategy and IC changes first and then 15 minutes for Orion. And of course no time left at the end for questions!
Fridays call will be much of the same - then the new marketing people rolling out their strategy that will surely “save” this brand. Because clearly it’s been a weak marketing strategy that has kept this drug from taking off not at all a lack of acquisition options!! Wink, wink

 

[anonymous]

Going over the new and improved start form. Offices are so sick of how hard it is to get a leqvio rx. It isn't even funny anymore. What an epic fail this is.

 

[anonymous]

novartis can certainly afford to offer their employees penile augmentation (even for the women). Entresto 24mg/26mg 60 count $647.30. Cosentyx 2 pens 150mg/ml $6,763.51. What is this company being reimbursed for these two drugs?

As far as I can see, all novartis is reimagining is playing the "me too" game with its portfolio of medicines. Please point out one unique product that novartis offers that is not comparable with another company's drug.

 

[anonymous]

novartis can certainly afford to offer their employees penile augmentation (even for the women). Entresto 24mg/26mg 60 count $647.30. Cosentyx 2 pens 150mg/ml $6,763.51. What is this company being reimbursed for these two drugs?

As far as I can see, all novartis is reimagining is playing the "me too" game with its portfolio of medicines. Please point out one unique product that novartis offers that is not comparable with another company's drug.

Reimagining data manipulation. Way to fucking go! How many of your scripts have some form of fraud associated with them? My guess is 85% +/-5%.

 

[anonymous]

Going over the new and improved start form. Offices are so sick of how hard it is to get a leqvio rx. It isn't even funny anymore. What an epic fail this is.

Now we have to go in those offices whose first experience was bad and convince them it wasn’t so bad.

 

[anonymous]

Now we have to go in those offices whose first experience was bad and convince them it wasn’t so bad.

We had an extra year to make the experience great. All leadership did was to tell us to smile when it doesn’t!

 

[anonymous]

How's Marie-France Tschudin working out? I tried to find a snide post from way back where someone from novartis was bragging about how they hire and promote women rather than bragging about how they hire and promote the most qualified candidates.